INTERNATIONAL PATENT: BRIGHT PEAK THERAPEUTICS AG FILES APPLICATION FOR "TARGETED IMMUNE ACTIVATION WITH IL-18 IMMUNOCYTOKINES"

GENEVA, March 3 -- BRIGHT PEAK THERAPEUTICS AG (Hegenheimermattweg 167/d4123 Allschwil) filed a patent application (PCT/IB2024/058236) for "TARGETED IMMUNE ACTIVATION WITH IL-18 IMMUNOCYTOKINES" on Aug 23, 2024. With publication no. WO/2025/041102, the details related to the patent application was published on Feb 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KREFT, Bertolt (Hegenheimermattweg 167/d4123 Allschwil), PATTABIRAMAN, Vijaya Raghavan (Hegenheimermattweg 167/d4123 Allschwil), CARRALOT, Jean-Philippe (Hegenheimermattweg 167/d4123 Allschwil), MARTIN, Kea (Hegenheimermattweg 167...